Home › Blog › Frightening Increase in Osteonecrosis in Patients taking Oral Steroids

Osteonecrosis Steroids Connection?  A study just published shows shocking amounts of increase in osteonecrosis in patients treated with oral steroids. Osteonecrosis or avascular necrosis (AVN) literally means “bone death”. This disease usually involves the hip and can mean a rapid collapse of the structure of the femur bone which causes severe arthritis. We’ve known for awhile that the single biggest easily preventable cause of osteonecrosis is the casual use of extremely powerful steroid medications by physicians. These medications are frequently used in patients who have flare-ups of severe arthritis, asthma, or sciatica.This new study now shows that just taking oral steroid medications for up to thirty days (commonly a week to 10 days) increased the likelihood of getting this dreaded disease on average 380%! For those unlucky enough to find themselves on these drugs for more than a year, the likelihood of being diagnosed with osteonecrosis went up 21,200%! As an interventional pain clinic, what’s very concerning to us is that we still see primary medicine physicians placing sciatica patients on these powerful and high risk steroid drugs. We hope this new data will educate physicians to exercise caution before prescribing these drugs, as we’ve seen many patients for stem cell treatment of their osteonecrosis who got the disease because of this preventable cause.

Learn More About Regenexx^® Procedures

Request a digital booklet and more information to learn about alternatives to orthopedic surgery and the Regenexx patient experience.

Your Email *

Include the weekly newsletter. It's free and you can unsubscribe at any time.

Submit

We do not sell, or share your information to third party vendors. By submitting the form you agree that you've read and consent to our Privacy Policy.

Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile